(Q36514879)

14 August 2017

1 reference

title

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? (English)

1 reference

14 August 2017

1 reference

Roland Haubner

1

1 reference

14 August 2017

1 July 2006

1 reference

14 August 2017

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

14 August 2017

33 Suppl 1

1 reference

14 August 2017

54-63

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-006-0136-0

14 August 2017

0 references

cites work

Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0136-0

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0136-0

Angiogenesis in psoriasis.

21 January 2018

1 reference

12 December 2020

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

1 reference

12 December 2020

In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands

1 reference

12 December 2020

Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta3 integrin related tumor imaging.

1 reference

12 December 2020

Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation

1 reference

12 December 2020

Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy

1 reference

12 December 2020

Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting

1 reference

12 December 2020

Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites

1 reference

12 December 2020

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

1 reference

12 December 2020

Solution structures and integrin binding activities of an RGD peptide with two isomers

1 reference

12 December 2020

Synopsis of angiogenesis inhibitors in oncology

1 reference

12 December 2020

A reevaluation of integrins as regulators of angiogenesis

1 reference

12 December 2020

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

1 reference

12 December 2020

Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy

1 reference

12 December 2020

Effect of pegylation on pharmaceuticals

1 reference

12 December 2020

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies

1 reference

12 December 2020

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

1 reference

12 December 2020

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs

1 reference

12 December 2020

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates

1 reference

12 December 2020

1 reference

12 December 2020

MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide

1 reference

12 December 2020

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

12 December 2020

Role of alpha v integrins during angiogenesis.

1 reference

12 December 2020

Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas

1 reference

12 December 2020

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

1 reference

12 December 2020

Tumor angiogenesis as a therapeutic target

1 reference

12 December 2020

Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD.

1 reference

12 December 2020

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

1 reference

12 December 2020

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

1 reference

12 December 2020

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

1 reference

12 December 2020

Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides

1 reference

12 December 2020

Angiogenesis factors.

1 reference

12 December 2020

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

1 reference

12 December 2020

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

1 reference

12 December 2020

Matrix metalloproteinases and angiogenesis

1 reference

12 December 2020

microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide

1 reference

12 December 2020

Angiogenesis in cancer and other diseases

1 reference

12 December 2020

Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression

1 reference

12 December 2020

Vascular-specific growth factors and blood vessel formation

1 reference

12 December 2020

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

1 reference

12 December 2020

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

1 reference

12 December 2020

In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging

1 reference

12 December 2020

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

1 reference

12 December 2020

New perspectives in cell adhesion: RGD and integrins

1 reference

12 December 2020

Pegylation: a novel process for modifying pharmacokinetics

1 reference

12 December 2020

Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues

1 reference

12 December 2020

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

1 reference

12 December 2020

PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.

1 reference

12 December 2020

Target molecules for anti-angiogenic therapy: from basic research to clinical trials

1 reference

12 December 2020

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

12 December 2020

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour

1 reference

12 December 2020

Angiogenesis in health and disease

1 reference

12 December 2020

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

1 reference

12 December 2020

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

1 reference

12 December 2020

Anti-angiogenic therapy: rationale, challenges and clinical studies

1 reference

12 December 2020

10.1007/S00259-006-0136-0

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16791598